These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15548813)

  • 1. The relation between c-myc expression and interferon sensitivity in uveal melanoma.
    Tulley PN; Neale M; Jackson D; Chana JS; Grover R; Cree I; Grobbelaar AO; Wilson GD
    Br J Ophthalmol; 2004 Dec; 88(12):1563-7. PubMed ID: 15548813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis.
    Lane AM; Egan KM; Harmon D; Holbrook A; Munzenrider JE; Gragoudas ES
    Ophthalmology; 2009 Nov; 116(11):2206-12. PubMed ID: 19744725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells.
    Gollob JA; Sciambi CJ
    Clin Cancer Res; 2007 Sep; 13(17):5219-25. PubMed ID: 17785578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
    Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
    J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells.
    Blom DJ; Goslings WR; De Waard-Siebinga I; Luyten GP; Claas FH; Gorter A; Jager MJ
    J Interferon Cytokine Res; 1997 Nov; 17(11):695-700. PubMed ID: 9402107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
    Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
    Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of c-myc oncogene expression in uveal melanoma.
    Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
    Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
    Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study.
    Dithmar S; Rusciano D; Lynn MJ; Lawson DH; Armstrong CA; Grossniklaus HE
    Arch Ophthalmol; 2000 Aug; 118(8):1085-9. PubMed ID: 10922203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
    Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
    Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon for melanoma.
    Richtig E; Langmann G
    Ophthalmology; 2010 Sep; 117(9):1861. PubMed ID: 20816255
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of bcl-2 in uveal malignant melanoma.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.
    Neale MH; Myatt NE; Khoury GG; Weaver P; Lamont A; Hungerford JL; Kurbacher CM; Hall P; Corrie PG; Cree IA
    Melanoma Res; 2001 Dec; 11(6):601-9. PubMed ID: 11725206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-inducible HtrA2 gene enhances radiosensitivity of uveal melanoma OCM-1 cells in vitro and in vivo.
    Zhang F; Yu T; Yi CL; Sun XF
    Clin Exp Ophthalmol; 2014 Nov; 42(8):761-8. PubMed ID: 24606398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.
    Elavathil LJ; LeRiche J; Rootman J; Gallagher RP; Phillips D
    Can J Ophthalmol; 1995 Dec; 30(7):360-5. PubMed ID: 8963937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
    Richardson RP; Lawry L; Rees RC; Rennie IG
    Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-myc oncogene expression in ocular melanomas.
    Royds JA; Sharrard RM; Parsons MA; Lawry J; Rees R; Cottam D; Wagner B; Rennie IG
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):366-71. PubMed ID: 1505770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Arch Ophthalmol; 2005 May; 123(5):654-61. PubMed ID: 15883285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.